September 25, 2023- Ontada, a McKesson business dedicated to leveraging oncology real-world data and evidence, clinical education, and provider technology, announced the appointment of Christine Davis as its new president.
In this role, Davis will focus on growing the business and fostering innovation, all to improve the lives of patients and win the fight against cancer. With more than 25 years of experience in the life sciences industry, Davis possesses an impressive background in oncology research and real-world data.
In her newly appointed position, Davis will advance Ontada’s real-world data and evidence services that are helping to accelerate drug development and commercialization, educate providers on new treatments, and advance precise, evidence-driven patient care.
Previously, Davis served as the Oracle Life Sciences’ Global Head of Commercial Research & Consulting for Cerner Enviza. She worked her way into life sciences leadership while at Kantar Health, a data analytics and research company focused on oncology and rare diseases later acquired by Cerner. At Kantar, Davis led the research business and directed U.S. primary research and analytics into opportunities for growth, differentiation, and innovation on behalf of the world’s top pharmaceutical companies. She later served as global head of oncology and specialty therapeutics where she led the company’s oncology data and products business.